NRX Pharmaceuticals (B1Q.F) Q4 2024 Earnings

14NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-0.68
-0.5
-0.32
-0.14

Details

Expected EPS
-0.5270613000000001
Actual EPS
-0.142449
Surprise EPS
0.38
Surprise Percent
+72.97%

Description

NRX Pharmaceuticals (B1Q.F) has reported earnings of -0.142449 per share for Q4 2024.

0 Comments

Share your thoughts